BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36652913)

  • 1. Size matters in non-canonical inflammasome activation and cell-mediated immunity.
    Weiss AM; Esser-Kahn AP
    Cell Rep Med; 2023 Jan; 4(1):100904. PubMed ID: 36652913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of inflammasomes in the immunostimulatory effects of particulate vaccine adjuvants.
    Harris J; Sharp FA; Lavelle EC
    Eur J Immunol; 2010 Mar; 40(3):634-8. PubMed ID: 20201019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of QS-21 as an Inflammasome-activating Molecular Component of Saponin Adjuvants.
    Marty-Roix R; Vladimer GI; Pouliot K; Weng D; Buglione-Corbett R; West K; MacMicking JD; Chee JD; Wang S; Lu S; Lien E
    J Biol Chem; 2016 Jan; 291(3):1123-36. PubMed ID: 26555265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NLRP3 inflammasome activation and cytotoxicity induced by particulate adjuvants.
    Yang M; Hearnden CH; Oleszycka E; Lavelle EC
    Methods Mol Biol; 2013; 1040():41-63. PubMed ID: 23852596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. K⁺ drops tilt the NLRP3 inflammasome.
    Kanneganti TD; Lamkanfi M
    Immunity; 2013 Jun; 38(6):1085-8. PubMed ID: 23809157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural mechanisms in NLR inflammasome signaling.
    Lechtenberg BC; Mace PD; Riedl SJ
    Curr Opin Struct Biol; 2014 Dec; 29():17-25. PubMed ID: 25201319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of adaptive immunity by the NLRP3 inflammasome.
    Chen M; Wang H; Chen W; Meng G
    Int Immunopharmacol; 2011 May; 11(5):549-54. PubMed ID: 21118671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutting edge: inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3.
    Li H; Willingham SB; Ting JP; Re F
    J Immunol; 2008 Jul; 181(1):17-21. PubMed ID: 18566365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the NLRP3 inflammasome is not a feature of all particulate vaccine adjuvants.
    Neumann S; Burkert K; Kemp R; Rades T; Rod Dunbar P; Hook S
    Immunol Cell Biol; 2014 Jul; 92(6):535-42. PubMed ID: 24687021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy.
    Demento SL; Eisenbarth SC; Foellmer HG; Platt C; Caplan MJ; Mark Saltzman W; Mellman I; Ledizet M; Fikrig E; Flavell RA; Fahmy TM
    Vaccine; 2009 May; 27(23):3013-21. PubMed ID: 19428913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of impaired NLRP3 inflammasome priming by monophosphoryl lipid A.
    Embry CA; Franchi L; Nuñez G; Mitchell TC
    Sci Signal; 2011 May; 4(171):ra28. PubMed ID: 21540455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myxoma virus lacking the pyrin-like protein M013 is sensed in human myeloid cells by both NLRP3 and multiple Toll-like receptors, which independently activate the inflammasome and NF-κB innate response pathways.
    Rahman MM; McFadden G
    J Virol; 2011 Dec; 85(23):12505-17. PubMed ID: 21957307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation and Function of the Nucleotide Binding Domain Leucine-Rich Repeat-Containing Receptor, Pyrin Domain-Containing-3 Inflammasome in Lung Disease.
    Lee S; Suh GY; Ryter SW; Choi AM
    Am J Respir Cell Mol Biol; 2016 Feb; 54(2):151-60. PubMed ID: 26418144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional crosstalk between non-canonical caspase-11 and canonical NLRP3 inflammasomes during infection-mediated inflammation.
    Yi YS
    Immunology; 2020 Feb; 159(2):142-155. PubMed ID: 31630388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GPRC6A mediates Alum-induced Nlrp3 inflammasome activation but limits Th2 type antibody responses.
    Quandt D; Rothe K; Baerwald C; Rossol M
    Sci Rep; 2015 Nov; 5():16719. PubMed ID: 26602597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular acidosis is a novel danger signal alerting innate immunity via the NLRP3 inflammasome.
    Rajamäki K; Nordström T; Nurmi K; Åkerman KE; Kovanen PT; Öörni K; Eklund KK
    J Biol Chem; 2013 May; 288(19):13410-9. PubMed ID: 23530046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Canonical Inflammasomes.
    Leal VNC; Pontillo A
    Methods Mol Biol; 2023; 2696():1-27. PubMed ID: 37578712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammasome-independent role of the apoptosis-associated speck-like protein containing CARD (ASC) in the adjuvant effect of MF59.
    Ellebedy AH; Lupfer C; Ghoneim HE; DeBeauchamp J; Kanneganti TD; Webby RJ
    Proc Natl Acad Sci U S A; 2011 Feb; 108(7):2927-32. PubMed ID: 21270336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Adjuvant Combination of dmLT and Monophosphoryl Lipid A Activates the Canonical, Nonpyroptotic NLRP3 Inflammasome in Dendritic Cells and Significantly Interacts to Expand Antigen-Specific CD4 T Cells.
    Bauer DL; Bachnak L; Limbert VM; Horowitz RM; Baudier RL; D'Souza SJ; Immethun VE; Kurtz JR; Grant SB; McLachlan JB
    J Immunol; 2023 May; 210(10):1519-1530. PubMed ID: 37023458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome.
    Sharp FA; Ruane D; Claass B; Creagh E; Harris J; Malyala P; Singh M; O'Hagan DT; Pétrilli V; Tschopp J; O'Neill LA; Lavelle EC
    Proc Natl Acad Sci U S A; 2009 Jan; 106(3):870-5. PubMed ID: 19139407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.